Medicinal chemistry strategies for discovering antivirals effective against drug-resistant viruses
Y Ma, E Frutos-Beltrán, D Kang… - Chemical Society …, 2021 - pubs.rsc.org
During the last forty years we have witnessed impressive advances in the field of antiviral
drug discovery culminating with the introduction of therapies able to stop human …
drug discovery culminating with the introduction of therapies able to stop human …
Tailor‐made amino acids and fluorinated motifs as prominent traits in modern pharmaceuticals
Structural analysis of modern pharmaceutical practices allows for the identification of two
rapidly growing trends: the introduction of tailor‐made amino acids and the exploitation of …
rapidly growing trends: the introduction of tailor‐made amino acids and the exploitation of …
[HTML][HTML] The utilization of spirocyclic scaffolds in novel drug discovery
YJ Zheng, CM Tice - Expert opinion on drug discovery, 2016 - Taylor & Francis
Spirocycles are ring systems in which two rings are fused through a single atom, referred to
as the spiro atom. The ethylene glycol ketal of cyclohexanone is an example of a well-known …
as the spiro atom. The ethylene glycol ketal of cyclohexanone is an example of a well-known …
Current therapy for chronic hepatitis C: The role of direct-acting antivirals
G Li, E De Clercq - Antiviral research, 2017 - Elsevier
One of the most exciting developments in antiviral research has been the discovery of the
direct-acting antivirals (DAAs) that effectively cure chronic hepatitis C virus (HCV) infections …
direct-acting antivirals (DAAs) that effectively cure chronic hepatitis C virus (HCV) infections …
Drug design strategies to avoid resistance in direct-acting antivirals and beyond
Drug resistance is prevalent across many diseases, rendering therapies ineffective with
severe financial and health consequences. Rather than accepting resistance after the fact …
severe financial and health consequences. Rather than accepting resistance after the fact …
Hepatitis C virus NS3/4a protease inhibitors
JA McCauley, MT Rudd - Current opinion in pharmacology, 2016 - Elsevier
Highlights•The development of numerous HCV NS3/4a protease inhibitors that entered
clinical trials is discussed.•Structural breakthroughs that influenced the field are …
clinical trials is discussed.•Structural breakthroughs that influenced the field are …
Amino Acid and Peptide‐Based Antiviral Agents
AS Skwarecki, MG Nowak, MJ Milewska - ChemMedChem, 2021 - Wiley Online Library
A significant number of antiviral agents used in clinical practice are amino acids, short
peptides, or peptidomimetics. Among them, several HIV protease inhibitors (eg lopinavir …
peptides, or peptidomimetics. Among them, several HIV protease inhibitors (eg lopinavir …
One-pot, catalyst-free synthesis of spiro [dihydroquinoline-naphthofuranone] compounds from isatins in water triggered by hydrogen bonding effects
D Kong, G Lu, M Wu, Z Shi, Q Lin - ACS Sustainable Chemistry & …, 2017 - ACS Publications
A one-pot, catalyst-free route to spiro [dihydroquinoline-naphthofuranone] compounds from
isatins through ring-opening and cyclization processes in water is disclosed. Hydrogen …
isatins through ring-opening and cyclization processes in water is disclosed. Hydrogen …
[HTML][HTML] Targeting HIV/HCV coinfection using a machine learning-based multiple quantitative structure-activity relationships (multiple QSAR) method
Y Wei, W Li, T Du, Z Hong, J Lin - International journal of molecular …, 2019 - mdpi.com
Human immunodeficiency virus type-1 and hepatitis C virus (HIV/HCV) coinfection occurs
when a patient is simultaneously infected with both human immunodeficiency virus type-1 …
when a patient is simultaneously infected with both human immunodeficiency virus type-1 …
Hepatitis C: The Story of a Long Journey through First, Second, and Third Generation NS3/4A Peptidomimetic Inhibitors. What Did We Learn?
SD Martino, GL Petri, M De Rosa - Journal of Medicinal Chemistry, 2024 - ACS Publications
Hepatitis C viral (HCV) infection is the leading cause of liver failure and still represents a
global health burden. Over the past decade, great advancements made HCV curable, and …
global health burden. Over the past decade, great advancements made HCV curable, and …